Dacula, Sittie Alisha A.
HRN: 21-57-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/20/2022
08/26/2022
IVT
15mg
Q8
T/C Necrotizing Enterocolitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes